Complete Omega Lemon

Complete Omega Lemon

Nordic Naturals4.8 (1,620 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 30 servings
Goals

Product analysis

55 out of 100

Complete Omega Lemon combines several omega fats in a formula that appears well aligned with its intended use. The unspecified oil forms make direct quality comparisons harder.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The oil forms are unspecified in the ingredient disclosure. That limits a reliable comparison of their quality.

Ingredient Transparency63

Amounts are disclosed for the listed nutrients. Missing oil-form details make it harder to compare what those amounts represent.

Value For Money63

Value is mixed but reasonably encouraging across the omega fats. Omega-6 and omega-9 compare more favorably than omega-3.

Customer Satisfaction86

Customer feedback is very positive across a substantial review base. Those ratings describe satisfaction rather than confirming health benefits.

Product Focus71

The formula stays concentrated on one intended goal. Its alignment with that purpose appears encouraging.

Format
Softgel
Container
60 Softgel(s)
Per serving
$0.50
Customer rating
4.8 · 1,620 ratings
Report analysis

Goals

Skin Health
Impact
High effect
B+ Ingredient FitF PathwaysB EvidenceA+ Formulation Logic
Omega-3 · 565 mg

Omega-3 fatty acids connect to skin lipids, but generic amounts do not reproduce the specific purified-EPA UV studies. GLA-related hydration findings came from defined evening-primrose or borage oils; its presence and amount remain unresolved here. Oil mass cannot establish a GLA dose. The saved partial barrier-lipid contribution does not establish routine hydration or dermatitis-treatment benefit.

How this product is rated for Skin Health

Ingredient fit83

The relevant ingredients provide a focused skin-health connection. Declared amounts partly meet the saved exposure references.
Goal fit
Relevant ingredients dominate the skin-health fit; links to other goals broaden the product's focus.
Dose adequacy
Amounts provide partial coverage of the saved exposure references; unknown quantities do not establish a usable skin-study exposure.

Pathways17

The strongest saved connection concerns epidermal barrier lipids. No assessed pathways reach the breadth threshold.
Depth
The strongest saved connection concerns epidermal barrier lipids, without proving an improvement in that skin outcome.
Breadth
No assessed pathways reach the saved breadth threshold.

Evidence78

Omega-3 leads the saved evidence contribution. The preparation check is satisfied for included ingredients, without establishing routine cosmetic improvement.
Evidence strength
Omega-3 supplies the leading contribution, subject to its specific outcome and population limits.
Studied preparation
Included ingredients satisfy the saved preparation check; this does not prove efficacy of the finished product.

Formulation logic100

No required partner is missing and no configured conflict was matched. Included ingredients clear the minimum amount comparison.
Partner coverage
No required partner is missing from the included contributions.
Conflicts
No configured ingredient conflict was matched.
Effective doses
Included ingredients clear the minimum amount comparison; this is distinct from a proven skin-treatment dose.
Study evidence
Omega-3 Supportive 35 studies
Omega-6 Adverse 9 studies
Omega-9 Not classified

No linked studies yet.

Ingredients

IngredientAmount per servingScore
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Total Omega-3 Fatty Acids
565 mg 74
Omega-6 Fatty Acids
240 mg 76
Omega-9 Fatty Acids
225 mg 76
Gluten Free Adults 18–50 Dairy Free
Report overview
Omega-9 · 225 mg OverallScore76
A- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB- Value
Omega-6 · 240 mg OverallScore76
C Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB+ Value
A serving provides 240 mg of omega-6, including 70 mg of gamma-linolenic acid (GLA). The remaining omega-6 and the specific oil source are not identified in the saved facts.
How this ingredient is rated

Active Ingredient Quality & Bioavailability64

GLA is identified at 70 mg per serving, but the saved facts do not name its oil source or identify the remaining omega-6. No extraction method is recorded in the saved facts.
Omega-6 Source & GLA Content
GLA is identified at 70 mg per serving, but the saved facts do not name its oil source or identify the remaining omega-6.
Extraction Method & Purity
No extraction method is recorded in the saved facts.

Dose, Safety & Label Transparency85

A serving contains 240 mg omega-6, including 70 mg of GLA; the remaining fatty acids are not identified in the saved facts.
Omega-6 Potency vs. Median
A serving contains 240 mg of omega-6.
Fatty Acid Profile Transparency
GLA is listed at 70 mg per serving; the rest of the omega-6 is not broken down in the saved facts.

Value80

A whole-product serving costs about $0.50.
Price Per Serving Efficiency
A whole-product serving costs about $0.50.
Omega-3 · 565 mg OverallScore74
A+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD+ Value
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  2. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  3. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  4. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  5. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  6. Psychosocial Burden in People with Atopic Dermatitis: Effects of a Substance-Free Basic Skincare in a Randomized Health Care Study.
    Braren-von Stülpnagel C; Augustin M; Sommer R; Westphal L · Skin pharmacology and physiology · 2024
    Randomized trial79 participantsSkin Health forOmega-6
  7. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis.
    Schäfer L; Kragballe K · The Journal of investigative dermatology · 1991
    Cross-sectional study15 participantsSkin Health forOmega-6
  8. Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years.
    Pike KC; Calder PC; Inskip HM; Robinson SM; Roberts GC; Cooper C; Godfrey KM; Lucas JS · Clinical & developmental immunology · 2013
    Cohort study865 participantsSkin Health forOmega-6
  9. Plasma omega-3 and omega-6 concentrations and risk of cutaneous basal and squamous cell carcinomas in Australian adults.
    Wallingford SC; Hughes MC; Green AC; van der Pols JC · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Cohort study1,191 participantsSkin Health forOmega-6
  10. Maternal PUFA status and offspring allergic diseases up to the age of 18 months.
    Yu YM; Chan YH; Calder PC; Hardjojo A; Soh SE; Lim AL; Fisk HL; Teoh OH; Goh A; Saw SM; Kwek K; Gluckman PD; Godfrey KM; Chong YS; Shek LP; Pan A; Chong MF; van Bever HP; GUSTO study group · The British journal of nutrition · 2015
    Cohort study960 participantsSkin Health forOmega-6